50 billion pounds could cure GSK’s malaise
Investors are aware of the risks of litigation against the maker of Zantac, once a great heartburn remedy. But it seems that the sudden decision toGSK(GSK Plc) by chapterHalion(Haleon Plc), which specializes in consumer healthcare, rather than selling it, is costly. Halion, which is behind brands like Sensodyne Pain Relief Toothpaste and Panadol, was a …